EasyBand GOAL Trial

NCT00534339 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-10-07

No results posted yet for this study

Summary

Safety, effectiveness, and performance of Allergan's EasyBand telemetrically adjustable gastric banding device for the treatment of morbidly obese patients.

Conditions

  • Morbid Obesity

Interventions

DEVICE

Easyband (Telemetrically adjustable gastric banding device)

EasyBand

Sponsors & Collaborators

  • Allergan Medical

    lead INDUSTRY

Principal Investigators

  • Allergan Medical · Allergan Medical

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-04-30
Completion
2016-02-29

Countries

  • United States
  • Canada

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00534339 on ClinicalTrials.gov